Global Pharmaceutical Contract Manufacturing Market Opportunities and Forecast 2020-2027

  • DLR2131
  • 23 November, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Pharmaceutical Contract Manufacturing Market, By Service (Packaging, Drug Dose Formulation, Active Pharmaceutical Ingredient (API)) By Technology (Low-Tech Manufactures, High-Tech Manufactures), and opportunities and forecast 2020-2027

Pharmaceutical Contract Manufacturing Market Overview

The use of medicines and treatments for well-being has expanded dramatically during the last several decades. With a limited number of blockbuster pharmaceuticals and increasing demand for innovative drugs, prominent pharmaceutical companies are attempting to stay competitive by completing drug development faster and at a lower cost. Furthermore, after the drug has received regulatory approval, these corporations have a shorter time to get the drug to market in large quantities. As a result of these issues, pharmaceutical contract manufacturers are increasingly outsourcing manufacturing facilities.
 
Furthermore, the global pharmaceutical contract manufacturing market is being bolstered by an infusion of tiny and virtual firms with limited manufacturing capacity. The increasing number of FDA-approved production facilities in developing nations is also helping to drive market expansion.
 
On the other hand, contract manufacturing companies' profitability is being harmed by capacity utilization challenges and a lack of manufacturing standardization. As a result, the market's overall revenue creation is hampered. In addition, rising logistics costs and lead times are causing distrust among pharmaceutical businesses, preventing the global pharmaceutical contract manufacturing market from reaching its full potential. The growing need for next-generation biological therapies, on the other hand, is providing producers with new opportunities in the global market.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Service, Technology, and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Althea Technologies, Aenova, Dishman Pharmaceuticals and Chemicals Limited, Catalent Pharma Solutions, HAUPT Pharma AG, Famar, Kemwell Pvt. Ltd., Jubilant Life Sciences Limited, Nipro Corp., NextPharma, Recipharm, Pfizer Central Source, Royal DSM N.V.


Covid-19 Impact on Pharmaceutical Contract Manufacturing Market
 
In addition, the current Pharmaceutical Contract Manufacturing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Pharmaceutical Contract Manufacturing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Pharmaceutical Contract Manufacturing Market Segment Overview



According to Service, Packaging is one of the most important segments in the global Pharmaceutical Contract Manufacturing market. The load or size of pharmaceuticals exported and imported through manufacturing and selling organizations is dealt with by packaging. Drug Dose Formulation refers to the injectable, liquid, and solid forms of pharmaceuticals that are made available to patients. APIs are small and large molecules that vary in size based on the severity of the ailment for which the medications are prescribed. Furthermore, by technology, this market is divided into low-tech and high-tech manufactures. It deals with the process knowledge by manufacturers to deal with specific drugs.
 
Pharmaceutical Contract Manufacturing Market, By Service
·       Packaging
·       Drug Dose Formulation
·       Active Pharmaceutical Ingredient (API)
 
Pharmaceutical Contract Manufacturing Market, By Technology
·       Low-Tech Manufactures
·       High-Tech Manufactures
 
Pharmaceutical Contract Manufacturing Market Regional Overview

Geographically, North America and Europe are important regions in the global pharmaceutical contract manufacturing market. The expanding geriatric population and strong adoption of biologics contribute to the growth of these regions. Biotechnology companies' increased research activities, as well as the expanding need for generics, are both contributing to the areas' growth. In the North American market, the United States will be a big income source. Due to growing healthcare infrastructure and increasing favorable government efforts, the Asia Pacific region is expected to emerge as a lucrative market throughout the forecast period.
 
Pharmaceutical Contract Manufacturing Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Pharmaceutical Contract Manufacturing Market, Key Players

·       Althea Technologies
·       Aenova
·       Dishman Pharmaceuticals and Chemicals Limited
·       Catalent Pharma Solutions
·       HAUPT Pharma AG
·       Famar
·       Kemwell Pvt. Ltd.
·       Jubilant Life Sciences Limited
·       Nipro Corp.
·       NextPharma
·       Recipharm
·       Pfizer Central Source
·       Royal DSM N.V.
 
 

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the Pharmaceutical Contract Manufacturing market?

A. The global pharmaceutical contract manufacturing market is being bolstered by an infusion of tiny and virtual firms with limited manufacturing capacity.

Q2. Which Segments are covered in the Pharmaceutical Contract Manufacturing Market report?

A. Service, Technology, and Region these segments are covered in the Pharmaceutical Contract Manufacturing market report.

Q3. Which segment is projected to hold the largest share in the Pharmaceutical Contract Manufacturing Market. ?

A. The packaging segment is projected to hold the largest share in the Pharmaceutical Contract Manufacturing Market.

Q4. Which region holds the largest share in the Pharmaceutical Contract Manufacturing market?

A. North America and Europe held the largest share in the global Pharmaceutical Contract Manufacturing market.

Q5. Which are the prominent players in the Pharmaceutical Contract Manufacturing Market?

A. Althea Technologies, Aenova, Dishman Pharmaceuticals and Chemicals Limited, Catalent Pharma Solutions, HAUPT Pharma AG, Famar, Kemwell Pvt. Ltd., Jubilant Life Sciences Limited, Nipro Corp., NextPharma, Recipharm, Pfizer Central Source, Royal DSM N.V. are some key players in the Pharmaceutical Contract Manufacturing Market.
Pharmaceutical Contract Manufacturing Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Pharmaceutical Contract Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Service
        • 5.2.1. Packaging
        • 5.2.2. Drug Dose Formulation
        • 5.2.3. Active Pharmaceutical Ingredient (API)
      • 5.3. Market Analysis, Insights and Forecast – By Technology
        • 5.3.1. Low-Tech Manufactures
        • 5.3.2. High-Tech Manufactures
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Pharmaceutical Contract Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Service
        • 6.2.1. Packaging
        • 6.2.2. Drug Dose Formulation
        • 6.2.3. Active Pharmaceutical Ingredient (API)
      • 6.3. Market Analysis, Insights and Forecast – By Technology
        • 6.3.1. Low-Tech Manufactures
        • 6.3.2. High-Tech Manufactures
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Pharmaceutical Contract Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Service
        • 7.2.1. Packaging
        • 7.2.2. Drug Dose Formulation
        • 7.2.3. Active Pharmaceutical Ingredient (API)
      • 7.3. Market Analysis, Insights and Forecast – By Technology
        • 7.3.1. Low-Tech Manufactures
        • 7.3.2. High-Tech Manufactures
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Service
        • 8.2.1. Packaging
        • 8.2.2. Drug Dose Formulation
        • 8.2.3. Active Pharmaceutical Ingredient (API)
      • 8.3. Market Analysis, Insights and Forecast – By Technology
        • 8.3.1. Low-Tech Manufactures
        • 8.3.2. High-Tech Manufactures
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Pharmaceutical Contract Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Service
        • 9.2.1. Packaging
        • 9.2.2. Drug Dose Formulation
        • 9.2.3. Active Pharmaceutical Ingredient (API)
      • 9.3. Market Analysis, Insights and Forecast – By Technology
        • 9.3.1. Low-Tech Manufactures
        • 9.3.2. High-Tech Manufactures
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Althea Technologies
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Aenova
      • 10.6. Dishman Pharmaceuticals and Chemicals Limited
      • 10.7. Catalent Pharma Solutions
      • 10.8. HAUPT Pharma AG
      • 10.9. Famar
      • 10.10. Kemwell Pvt. Ltd.
      • 10.11. Jubilant Life Sciences Limited
      • 10.12. Nipro Corp.
      • 10.13. NextPharma
      • 10.14. Recipharm
      • 10.15. Pfizer Central Source
      List of Figures

      Figure 1: Global Pharmaceutical Contract Manufacturing Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Pharmaceutical Contract Manufacturing Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934